The First Annual State of Regenerative Survey, 2020 Edition takes the pulse of Regenerative Medicine in the U.S., addressing controversial topics like Regenerative Medicare Reimbursement, Exosomes, Stem Cell Therapies, and Bad Actors.
2020 has brought chaos to many industries and the Regenerative Marketplace is not the least of them. Many clinics forced to shut down have not reopened while the appointment of a new FDA commissioner with strong opinions about stem cells casts doubts on where the future lies for many Regenerative Practitioners. Historically, conferences have been the hub of information the industry needs for current data and up to date status of the industry. Yet, these conferences have been canceled while Regenerative Covid-19 fast tracks are enabling Regenerative Manufacturers to obtain INDs who otherwise would be waiting for years.
State of Regenerative, 2020 Edition is an in-depth survey sponsored by veteran Regenerative Supply Distributor Dallas Regenerative Solutions. This survey seeks to tap the collective intellect of the dynamic, evolving Medical Art of Regenerative Medicine in the U.S. and provide practitioners a map of the new terrain unfolding before us.
The survey takes less than 10 minutes to complete and covers topics from FDA Regulations to Outcomes, Credentialing, Product Warnings and Credibility. Participants will receive a complimentary copy of the First Annual State of Regenerative Survey, 2020 Edition results for their time taking the survey, as well as exclusive live updates as data becomes available.
The survey may be accessed at the Dallas Regenerative website www.dallasregenerativellc.com by tapping the “Take Survey now” button or you can access the survey directly at www.
Live updates will be available on LinkedIn at https://www.linkedin.com/company/dallas-regenerative-solutions/.